| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 16:49:29 UTC |
|---|
| Updated at | 2022-04-28 16:49:29 UTC |
|---|
| NP-MRD ID | NP0071443 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (-)-Linckoside M |
|---|
| Description | (1R,2R,5S,8R,10S,11S,12R,13R,14R,15R)-5-{[(2S,3R,4S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-14-[(2S,3E,5R,6S)-5,6-dimethyl-7-{[(2S,3R,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]Heptadec-6-ene-8,10,12,13-tetrol belongs to the class of organic compounds known as ergostane steroids. These are steroids with a structure based on the ergostane skeleton, which arises from the methylation of cholestane at the 24-position. (-)-Linckoside M is found in Linckia laevigata. Based on a literature review very few articles have been published on (1R,2R,5S,8R,10S,11S,12R,13R,14R,15R)-5-{[(2S,3R,4S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-14-[(2S,3E,5R,6S)-5,6-dimethyl-7-{[(2S,3R,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]Heptadec-6-ene-8,10,12,13-tetrol. |
|---|
| Structure | CO[C@H]1[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H]([C@@H](C)\C=C\[C@@H](C)[C@H](C)CO[C@H]6OC[C@@H](O)[C@@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5[C@]4(O)C[C@@H](O)C3=C2)OC[C@@H](O)[C@@H]1O InChI=1S/C39H64O14/c1-18(20(3)15-50-35-32(47)28(43)24(41)16-51-35)7-8-19(2)27-30(45)31(46)34-38(27,5)12-10-26-37(4)11-9-21(13-22(37)23(40)14-39(26,34)48)53-36-33(49-6)29(44)25(42)17-52-36/h7-8,13,18-21,23-36,40-48H,9-12,14-17H2,1-6H3/b8-7+/t18-,19+,20-,21+,23-,24-,25-,26-,27+,28-,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+/m1/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C39H64O14 |
|---|
| Average Mass | 756.9270 Da |
|---|
| Monoisotopic Mass | 756.42961 Da |
|---|
| IUPAC Name | (1R,2R,5S,8R,10S,11S,12R,13R,14R,15R)-5-{[(2S,3R,4S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-14-[(2S,3E,5R,6S)-5,6-dimethyl-7-{[(2S,3R,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-8,10,12,13-tetrol |
|---|
| Traditional Name | (1R,2R,5S,8R,10S,11S,12R,13R,14R,15R)-5-{[(2S,3R,4S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-14-[(2S,3E,5R,6S)-5,6-dimethyl-7-{[(2S,3R,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}hept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-8,10,12,13-tetrol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CO[C@H]1[C@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@@H]([C@@H](C)\C=C\[C@@H](C)[C@H](C)CO[C@H]6OC[C@@H](O)[C@@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5[C@]4(O)C[C@@H](O)C3=C2)OC[C@@H](O)[C@@H]1O |
|---|
| InChI Identifier | InChI=1S/C39H64O14/c1-18(20(3)15-50-35-32(47)28(43)24(41)16-51-35)7-8-19(2)27-30(45)31(46)34-38(27,5)12-10-26-37(4)11-9-21(13-22(37)23(40)14-39(26,34)48)53-36-33(49-6)29(44)25(42)17-52-36/h7-8,13,18-21,23-36,40-48H,9-12,14-17H2,1-6H3/b8-7+/t18-,19+,20-,21+,23-,24-,25-,26-,27+,28-,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+/m1/s1 |
|---|
| InChI Key | OOJRJXRJAASSJR-KSOYFHIOSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ergostane steroids. These are steroids with a structure based on the ergostane skeleton, which arises from the methylation of cholestane at the 24-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Ergostane steroids |
|---|
| Direct Parent | Ergostane steroids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ergostane-skeleton
- Steroidal glycoside
- 16-hydroxysteroid
- 16-beta-hydroxysteroid
- Hydroxysteroid
- 15-hydroxysteroid
- 6-hydroxysteroid
- Delta-4-steroid
- O-glycosyl compound
- Glycosyl compound
- Oxane
- Monosaccharide
- Tertiary alcohol
- Cyclic alcohol
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Ether
- Dialkyl ether
- Acetal
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|